Brodalumab efficacy in psoriasis patients with inadequate response to IL-23 or IL-12/23 inhibitors: multicenter Italian retrospective analysis - IL PSO (Italian Landscape Psoriasis)

Our results are in line with the current literature and suggest that patients who have failed therapy with IL-23 or IL-12/23 inhibitors may benefit from switching to brodalumab, which could be considered a good choice for patients who need a rapid resolution of the inflammatory skin condition.

Authors

Institutions

Publication Details

Journal
Dermatology Practical & Conceptual
Published
2025-10-31
DOI
https://doi.org/10.5826/dpc.1504a6010
Primary Topic
Psoriasis: Treatment and Pathogenesis
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Brodalumab efficacy in psoriasis patients with inadequate response to IL-23 or IL-12/23 inhibitors: multicenter Italian retrospective analysis - IL PSO (Italian Landscape Psoriasis)

Diego Orsini, Giovanni Carlo Lazzaro Danzuso, Vincenzo Panasiti, Simone Ribero et al.
Dermatology Practical & Conceptual
Psoriasis: Treatment and Pathogenesis
article

Brodalumab efficacy in psoriasis patients with inadequate response to IL-23 or IL-12/23 inhibitors: multicenter Italian retrospective analysis - IL PSO (Italian Landscape Psoriasis)

Diego Orsini, Giovanni Carlo Lazzaro Danzuso, Vincenzo Panasiti, Simone Ribero, Agostina Legori, Andrea Muracchioli, Ginevra Baggini, Anna Elisabetta Cagni, Maria Esposito, Annunziata Dattola, Matteo Megna, Claudio Guarneri, Martino Carriero, Emanuele Cozzani, Leonardo Zichichi, Federica Mola, Matteo Licciardello, Massimo Travaglini, Piergiorgio Malagoli, Anna Campanati, Andrea Musumeci, Francesca Graziola, Paolo Dapavo, Chiara Assorgi, Marco Rubatto, Paolo Romita, Gianluca Calianno, Oriele Sarno, Marco Galluzzo, Antonio Costanzo, Giacomo Dal Bello, Luigi Bianchi, Martina Burlando, Dario Graceffa, Paolo Pella, Luisa Arancio, Viviana Lora, Franco Cona, Carmen Fiorella, Gaia Moretta, Fabrizio Vaira, Riccardo Balestri, Giacomo Caldarola, Andrea Carugno, Marianna Donnarumma, Antonio Carpentieri, Alessandra Narcisi, Daniele Rizzo, Gianluca Pagnanelli, Alexandra Maria Giovanna Brunasso, Elena Campione, Federico Diotallevi, Eugenio Provenzano, Antonio Di Tano, Maria Letizia Musumeci, Maria Concetta Fargnoli, Davide Strippoli, Elena De Col
article en

Abstract

Our results are in line with the current literature and suggest that patients who have failed therapy with IL-23 or IL-12/23 inhibitors may benefit from switching to brodalumab, which could be considered a good choice for patients who need a rapid resolution of the inflammatory skin condition.

Dermatology Practical & ConceptualVol. 15(4)
University of Messina (IT), University of Insubria (IT), University of Rome Tor Vergata (IT), Marche Polytechnic University (IT), Università degli Studi del Piemonte Orientale “Amedeo Avogadro” (IT), University of Milan (IT), University of L'Aquila (IT), Association for Symbolic Logic (US), Agostino Gemelli University Polyclinic (IT), Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (IT), University of Catania (IT), IRCCS Policlinico San Donato (IT), Azienda Ospedaliera di Cosenza (IT), Ospedale A. Perrino (IT), Ospedale Sant Antonio (IT), Ospedale Garibaldi (IT), Azienda Ospedaliera San Gerardo (IT), Azienda Ospedaliera S.Giuseppe Moscati (IT), IRCCS Ospedale Galeazzi - Sant'Ambrogio (IT), Alessandro Manzoni Hospital (IT), Ospedale Koelliker (IT), Istituto Dermopatico dell'Immacolata (IT), CTO Andrea Alesini (IT), Azienda Ospedaliero Universitaria Maggiore della Carita (IT), Azienda Socio Sanitaria Territoriale Lariana (IT), Azienda Sanitaria Locale Alessandria (IT), IRCCS Ospedale San Raffaele (IT), San Gallicano Hospital (IT), Campus Bio Medico University Hospital (IT), Candiolo Cancer Institute (IT), University of the Sacred Heart (JP), Ospedale degli Infermi (IT), Istituti di Ricovero e Cura a Carattere Scientifico (IT), Gastroenterology Hospital "Saverio de Bellis" (IT), Villa Torri Hospital (IT), IRCCS Humanitas Research Hospital (IT), University of Turin (IT), University of Bari Aldo Moro (IT), University of Naples Federico II (IT), University of Genoa (IT), Sapienza University of Rome (IT)
Pfizer, Sun Pharma
Openalex Percentile: Top 67%
Psoriasis: Treatment and Pathogenesis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.